EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY-NC 4.0

Pharmacogenomic Clinical Decision Support: A Scoping Review

D Max Smith iD, Dyson T Wake, Henry M Dunnenberger iD

Clinical Pharmacology & Therapeutics · 2023-04 · 113 (4) · 803-815

DOI: 10.1002/cpt.2711 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 31.07.2022. Verfasst von D Max Smith und 2 weiteren Autor:innen. Beteiligte Einrichtung: MedStar Health, Columbia, Maryland, USA. Hauptthemen laut MEDLINE: Decision Support Systems, Clinical, Medical Order Entry Systems. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical decision support (CDS) is often cited as an essential part of pharmacogenomics (PGx) implementations. A multitude of strategies are available; however, it is unclear which strategies are effective and which metrics are used to quantify clinical utility. The objective of this scoping review was to aggregate previous studies into a cohesive depiction of the current state of PGx CDS implementations and identify areas for future research on PGx CDS. Articles were included if they (i) described electronic CDS tools for PGx and (ii) reported metrics related to PGx CDS. Twenty of 3,449 articles were included and provided data on PGx CDS metrics from 15 institutions, with 93% of programs located at academic medical centers. The most common tools in CDS implementations were interruptive post‐test alerts. Metrics for clinical response and alert response ranged from 12–73% and 21–98%, respectively. Few data were found on changes in metrics over time and measures that drove the evolution of CDS systems. Relatively few data were available regarding support of optimal approaches for PGx CDS. Post‐test alerts were the most widely studied approach, and their effectiveness varied greatly. Further research on the usability, effectiveness, and optimization of CDS tools is needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Decision Support Systems, ClinicalMedical Order Entry SystemsHumansPharmacogeneticsElectronic Health RecordsSoftware

Autor:innen und Institutionen

  • MedStar Health, Columbia, Maryland, USA.
  • Georgetown University Medical Center, Washington, District of Columbia, USA.
  • Mark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, Illinois, USA.

ORCID-Profile: D Max Smith, Henry M Dunnenberger

Zitieren

APA

Smith, D. M., Wake, D. T., & Dunnenberger, H. M. (2023). Pharmacogenomic Clinical Decision Support: A Scoping Review. Clinical Pharmacology & Therapeutics, 113(4), 803-815. https://doi.org/10.1002/cpt.2711

Vancouver

Smith DM, Wake DT, Dunnenberger HM. Pharmacogenomic Clinical Decision Support: A Scoping Review. Clinical Pharmacology & Therapeutics. 2023;113(4):803-815. doi:10.1002/cpt.2711

BibTeX
@article{Smith2023,
  author = {Smith, D Max and Wake, Dyson T and Dunnenberger, Henry M},
  title = {Pharmacogenomic Clinical Decision Support: A Scoping Review},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2023},
  volume = {113},
  number = {4},
  pages = {803--815},
  doi = {10.1002/cpt.2711}
}
Kostenlos starten →